Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ (117,473) $ (99,927)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 22,710 8,106
Amortization of debt issuance costs and discount 657 642
Equity-based compensation expense 50,635 35,598
Loss on extinguishment of debt 3,731 0
(Gain) loss on change in fair value of warrants 14,787 2,692
Deferred provision (benefit) for income taxes 2,485 (32,069)
Other 1,961 (3,677)
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable 9,553 (3,468)
(Increase) decrease in contract assets (28,388) (5,724)
(Increase) decrease in inventory (30,170) 1,449
(Increase) decrease in prepaid expenses and other assets 68 (3,024)
Increase (decrease) in accounts payable and accrued expenses 19,358 (5,586)
Increase (decrease) in deferred revenue 25,344 (28,433)
Increase (decrease) in operating lease liabilities (427) (55)
Increase (decrease) in other liabilities (7,433) 732
Increase (decrease) in notes payable to sellers 1,000 0
Net cash provided by (used in) operating activities (31,602) (132,744)
Cash flows from investing activities:    
Acquisition of businesses, net of cash acquired 0 (151,791)
Purchases of property, plant and equipment (13,287) (4,752)
Purchase of intangible assets (3,154) (5,186)
Net cash provided by (used in) investing activities (16,441) (161,729)
Cash flows from financing activities:    
Proceeds received from debt 89,728 190,327
Repayments of debt (129,537) (125,876)
Payment of debt issuance fees (1,914) (105)
Repayment of finance leases (294) (227)
Proceeds from (repayment of) third-party advances 0 (7,820)
Proceeds from issuance of common stock 566,243 328,684
Payment of equity issuance costs (13,881) 0
Proceeds from common stock issued for options exercise 4,155 0
Shares repurchased for settlement of employee tax withholdings on share-based awards 0 (8)
Convertible preferred stock dividend (3,039) 0
Repurchase of convertible preferred stock 0 (61,486)
Net cash provided by (used in) financing activities 511,461 323,489
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash (883) 472
Net increase (decrease) in cash, cash equivalents and restricted cash 462,535 29,488
Cash, cash equivalents and restricted cash at beginning of period 95,183 49,071
Cash, cash equivalents and restricted cash at end of period $ 557,718 $ 78,559